285 related articles for article (PubMed ID: 28547571)
1. Clinical presentations and molecular studies of invasive renal epithelioid angiomyolipoma.
Chuang CK; Lin HCA; Tasi HY; Lee KH; Kao Y; Chuang FL; Chang YH; Lin PH; Liu CY; Pang ST
Int Urol Nephrol; 2017 Sep; 49(9):1527-1536. PubMed ID: 28547571
[TBL] [Abstract][Full Text] [Related]
2. Advanced sporadic renal epithelioid angiomyolipoma: case report of an extraordinary response to sirolimus linked to TSC2 mutation.
Espinosa M; Roldán-Romero JM; Duran I; de Álava E; Apellaniz-Ruiz M; Cascón A; Garrigos C; Robledo M; Rodriguez-Antona C
BMC Cancer; 2018 May; 18(1):561. PubMed ID: 29764404
[TBL] [Abstract][Full Text] [Related]
3. Expression level of phosphorylated-4E-binding protein 1 in radical nephrectomy specimens as a prognostic predictor in patients with metastatic renal cell carcinoma treated with mammalian target of rapamycin inhibitors.
Nishikawa M; Miyake H; Harada K; Fujisawa M
Med Oncol; 2014 Jan; 31(1):792. PubMed ID: 24307346
[TBL] [Abstract][Full Text] [Related]
4. Dia-gnostic Challenges and Extraordinary Treatment Response in Rare Malignant PEComa Tumor of the Kidney.
Huľová S; Sycova-Mila Z; Macák D; Janega P; Chovanec M; Mardiak J; Mego M
Klin Onkol; 2018; 31(6):448-452. PubMed ID: 30545225
[TBL] [Abstract][Full Text] [Related]
5. Renal epithelioid angiomyolipoma: a rare variant with unusual behavior.
Hassan M; El-Hefnawy AS; Elshal AM; Mosbah A; El-Baz M; Shaaban A
Int Urol Nephrol; 2014 Feb; 46(2):317-22. PubMed ID: 23928927
[TBL] [Abstract][Full Text] [Related]
6. Treatment of renal angiomyolipoma in tuberous sclerosis complex (TSC) patients.
Brakemeier S; Bachmann F; Budde K
Pediatr Nephrol; 2017 Jul; 32(7):1137-1144. PubMed ID: 27585680
[TBL] [Abstract][Full Text] [Related]
7. A suggestion for pathological grossing and reporting based on prognostic indicators of malignancies from a pooled analysis of renal epithelioid angiomyolipoma.
Zheng S; Bi XG; Song QK; Yuan Z; Guo L; Zhang H; Ma JH
Int Urol Nephrol; 2015 Oct; 47(10):1643-51. PubMed ID: 26271644
[TBL] [Abstract][Full Text] [Related]
8. Next-generation sequencing reveals somatic mutations that confer exceptional response to everolimus.
Lim SM; Park HS; Kim S; Kim S; Ali SM; Greenbowe JR; Yang IS; Kwon NJ; Lee JL; Ryu MH; Ahn JH; Lee J; Lee MG; Kim HS; Kim H; Kim HR; Moon YW; Chung HC; Kim JH; Kang YK; Cho BC
Oncotarget; 2016 Mar; 7(9):10547-56. PubMed ID: 26859683
[TBL] [Abstract][Full Text] [Related]
9. Does epithelioid angiomyolipoma have poorer prognosis, compared with classic angiomyolipoma?
Lee W; Choi SY; Lee C; Yoo S; You D; Jeong IG; Song C; Kim KS; Hong B; Hong JH; Ahn H; Kim CS
Investig Clin Urol; 2018 Nov; 59(6):357-362. PubMed ID: 30402567
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemistry of p53 and Ki-67 and p53 mutation analysis in renal epithelioid angiomyolipoma.
Li W; Guo L; Bi X; Ma J; Zheng S
Int J Clin Exp Pathol; 2015; 8(8):9446-51. PubMed ID: 26464702
[TBL] [Abstract][Full Text] [Related]
11. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.
Korkolopoulou P; Levidou G; Trigka EA; Prekete N; Karlou M; Thymara I; Sakellariou S; Fragkou P; Isaiadis D; Pavlopoulos P; Patsouris E; Saetta AA
BJU Int; 2012 Dec; 110(11 Pt C):E1237-48. PubMed ID: 23107319
[TBL] [Abstract][Full Text] [Related]
12. Renal angiomyolipoma with tuberous sclerosis complex: How it differs from sporadic angiomyolipoma in both management and care.
Hatano T; Egawa S
Asian J Surg; 2020 Oct; 43(10):967-972. PubMed ID: 31959574
[TBL] [Abstract][Full Text] [Related]
13. Molecular Characterization of Malignant Renal Epithelioid Angiomyolipoma: A Review of Two Cases.
Rammal R; Korentzelos D; Skaugen JM; Quiroga-Garza GM
Am J Clin Pathol; 2023 Mar; 159(3):211-220. PubMed ID: 36661215
[TBL] [Abstract][Full Text] [Related]
14. Renal angiomyolipoma: Clinico-pathologic study of 17 cases with emphasis on the epithelioid histology and p53 gene abnormalities.
Boudaouara O; Kallel R; Dhieb D; Smaoui W; Ayed HB; Keskes L; Sellami Boudawara T
Ann Diagn Pathol; 2020 Aug; 47():151538. PubMed ID: 32574890
[TBL] [Abstract][Full Text] [Related]
15. Two novel TSC2 mutations in renal epithelioid angiomyolipoma sensitive to everolimus.
Wang T; Xie S; Luo R; Shi L; Bai P; Wang X; Wan R; Deng J; Wu Z; Li W; Xiao W; Wang Y; Chen B; Zhang K; Xing J
Cancer Biol Ther; 2020; 21(1):4-11. PubMed ID: 31597506
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Renal Angiomyolipoma and Other Hamartomas in Patients with Tuberous Sclerosis Complex.
Samuels JA
Clin J Am Soc Nephrol; 2017 Jul; 12(7):1196-1202. PubMed ID: 28302901
[TBL] [Abstract][Full Text] [Related]
17. Expression of molecular markers associated with the mammalian target of rapamycin pathway in nonmetastatic renal cell carcinoma: Effect on prognostic outcomes following radical nephrectomy.
Nishikawa M; Miyake H; Harada K; Fujisawa M
Urol Oncol; 2014 Jan; 32(1):49.e15-21. PubMed ID: 24239474
[TBL] [Abstract][Full Text] [Related]
18. Renal epithelioid angiomyolipoma with malignant features: Histological evaluation and novel immunohistochemical findings.
Konosu-Fukaya S; Nakamura Y; Fujishima F; Kasajima A; McNamara KM; Takahashi Y; Joh K; Saito H; Ioritani N; Ikeda Y; Arai Y; Watanabe M; Sasano H
Pathol Int; 2014 Mar; 64(3):133-41. PubMed ID: 24698423
[TBL] [Abstract][Full Text] [Related]
19. Clinical and pathological features of renal epithelioid angiomyolipoma (PEComa): A single institution series.
Saoud R; Kristof TW; Judge C; Chumbalkar V; Antic T; Eggener S; Modi P
Urol Oncol; 2022 Feb; 40(2):18-24. PubMed ID: 34815169
[TBL] [Abstract][Full Text] [Related]
20. Putative role of the mTOR/4E-BP1 signaling pathway in the carcinogenesis and progression of gastric cardiac adenocarcinoma.
Yang HY; Xue LY; Xing LX; Wang J; Wang JL; Yan X; Zhang XH
Mol Med Rep; 2013 Feb; 7(2):537-42. PubMed ID: 23229050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
